Tristel plc (AIM:TSTL)

Market Cap	189.89M +9.0%
Revenue (ttm)	49.54M +13.7%
Net Income	7.86M +28.1%
EPS	0.16 +26.1%
Shares Out	48.07M
PE Ratio	24.32
Forward PE	20.04
Dividend	0.14 (3.60%)
Ex-Dividend Date	Mar 19, 2026

Volume	67,658
Open	400.00
Previous Close	395.00
Day's Range	390.00 - 400.00
52-Week Range	350.00 - 450.00
Beta	0.34
Analysts	Strong Buy
Price Target	475.18 (+20.3%)
Earnings Date	Oct 12, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 270
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Analyst Summary

According to 6 analysts, the average rating for TSTL stock is "Strong Buy." The 12-month stock price target is 475p, which is an increase of 20.30% from the latest price.

Price Target

475p

(20.30% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error